Import alert · FDA Import Alerts (Industry 54)

Geranti Pharmaceutical Ltd.: FDA Import Alert 54-07 (May 22, 2024)

Agency action: May 22, 2024Record ID: 54-07|Geranti Pharmaceutical Ltd.|2024-05-22
View official source ↗

What happened

Original notice title

"Detention Without Physical Examination of Germanium Supplements for Human Consumption"

From the archived source record

"Detention Without Physical Examination of Germanium Supplements for Human Consumption". Firm/address: Geranti Pharmaceutical Ltd. Date Published : 05/22/2024 408 Teheran Ro 7 Gil 22 , Seoul, KOREA (THE REPUBLIC OF)

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Active/current Red List snapshot
Source checked
Jul 16, 2026
Record revision
2a3d3e3b2354

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Germanium products
Company
Geranti Pharmaceutical Ltd.
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.